UnitedHealth stock fills in the gap as market assesses the bottom is in

UNH stock rises more than 7%, closing the gap from May 15.
New CEO Stephen Hemsley buys $25 million worth of UNH stock.
Shareholders are still waiting to hear about the Justice Department's fraud probe of UnitedHealth.
US market largely slumps on Moody's downgrade of US government debt.

Clay Webster FXStreet

UnitedHealth Group (UNH), the largest private health insurer in the United States (US), has seen its share price rise more than 7% on Monday to fill the gap created by the May 15 plunge. Now trading north of $314, the daily chart portrays a sell-off that has likely already reached its bottom and has now begun a long trek higher toward a period of consolidation.

Wall Street analysts have largely lowered their price targets for UNH stock between $350 and $400.

The Dow Jones Industrial Average (DJIA) is largely being held up slightly by UNH gains, while the S&P 500 and the NASDAQ Composite both sink moderately lower as the market deals with the fallout from Moody's downgrading US debt late Friday.

UnitedHealth Group stock news

UNH stock has crated over the past month since mid-April when UnitedHealth cut its earnings guidance for 2025 by about 12% before suspending guidance entirely last week in the face of replacing its CEO.

However, former Chair and newly-installed CEO Stephen Hemsley purchased more than $25 million worth of UNH stock on Friday, according to filings with the Securities and Exchange Commission (SEC). The 86.7K shares that Hemsley bought were purchased at an average price of $288.57 and fortified bullish instincts that Thursday's five-year low at $248.88 was the bottom.

Three directors also purchased a combined $1.6 million worth of shares last Wednesday and Thursday, and CFO John Rex bought another 17.2K shares on Friday. This heavy level of insider buying tells the market that the company's executives don't expect recent news to be insurmountable.

Last week, according to The Wall Street Journal, the US Justice Department opened a fraud probe into UnitedHealth's Medicare Advantage business. The article suggests that the regulators are considering whether the company added unnecessary diagnoses to some patients' medical records.

UnitedHealth Group stock forecast

UnitedHealth Group stock has risen above the May 14 low at $307.11 on Monday. This fills in the gap created by May 15's much lower open.

Now trading north of $314, UNH shares have overcome the 161.8% Fibonacci Extension that briefly held up the deluge during the previous week. The next targets for bulls come at the 161.8% Fibonacci Retracement (not shown) at $334.76, the May 13 high at $342, and then the May 12 low at $376.84. Markets love to fill in gaps, so the retracement to $376.84 will be a major point of interest.

UNH daily stock chart

Author

Clay Webster

FXStreet

Clay Webster grew up in the US outside Buffalo, New York and Lancaster, Pennsylvania. He began investing after college following the 2008 financial crisis.

AUD/USD consolidates above 0.7000; remains close to monthly top

AUD/USD holds steady above 0.7000 during the Asian session on Friday, trading just below the previous day's monthly low amid diverging forces. A hawkish RBA continues to support the Aussie, while the recent decline in US bond yields keeps the US Dollar depressed near a three-week low. However, oil-driven inflation fears reinforce Fed hike bets, which, along with geopolitical risks, could benefit the safe-haven buck and cap the currency pair.

USD/JPY bounces off one-month low; climbs to 157.00 amid reviving USD demand

USD/JPY rebounds from the 156.00 neighborhood, or a one-month low touched during Friday’s Asian session, with bulls looking to extend momentum beyond 157.00 amid the emergence of some US Dollar buying. Meanwhile, Japan's National CPI rose to a nine-month peak and reaffirmed BoJ rate-hike bets, which could support the Japanese Yen and cap gains for the currency pair.

Gold stalls recovery from three-month low as Fed hike bets and USD uptick cap gains

Gold struggles to capitalize on a modest intraday bounce from levels below the $4,000 psychological mark, or a three-month low set during the Asian session, and sticks to a negative tone for the second straight day. The Federal Reserve recently signaled that there is no urgency to raise interest rates. Traders, however, are still pricing in around an 80% chance that the US central bank will raise borrowing costs again at its December policy meeting.

Bitcoin, Ethereum, and Ripple rebound as major support levels cap recent sell-off

Bitcoin, Ethereum and Ripple rebound modestly on Friday after correcting and testing their key support zone the previous day. BTC holds the 50-day EMA, ETH finds support around the 100-day EMA, while XRP holds the horizontal floor near $1.300. The price action of these top three cryptocurrencies suggests a recovery if this critical support zone holds; a decisive close below these levels suggests a deeper correction.

The week ahead – UK budget, Shell, BP and HSBC and NatWest results

Financial markets have undergone another turbulent week with concerns about public sector debt levels, the impact of energy policy and higher oil and gas prices, and what events in France might mean for the UK economy going forward.

What November 3 means for the Fed's rate path and the US Dollar

The USD faces a decisive period ahead of the November 3 midterm elections. While markets anticipate another interest rate increase from the Fed in December, the battle for control of Congress could reshape fiscal policy expectations and, indirectly, the path of US monetary policy in 2027.